Endogenous IL-33 exerts CD8
Antitumor immune responses
CD8(+) T cells
Colon carcinoma
IL-33
Regulatory T cells
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
15 10 2019
15 10 2019
Historique:
received:
02
08
2019
accepted:
09
08
2019
pubmed:
20
8
2019
medline:
17
6
2020
entrez:
19
8
2019
Statut:
ppublish
Résumé
Interleukin-33 (IL-33) is a nuclear-associated cytokine of the IL-1 family. IL-33 and its receptor ST2 axis exert conflicting anti-tumor and pro-tumor effects in various tumors. In this study, we examined the role of endogenously produced IL-33 in the colon-26 tumor model, in which involvement of the IL-33:ST2 pathway was negligible on the tumor side. We found that the generation of regulatory T cells (Tregs) and CD8
Identifiants
pubmed: 31421832
pii: S0006-291X(19)31575-X
doi: 10.1016/j.bbrc.2019.08.058
pii:
doi:
Substances chimiques
Il33 protein, mouse
0
Interleukin-33
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
331-336Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.